Finance

Beta
Lists
003120:KRX
Ilsung IS Co Ltd
₩19,960.00
-0.05%
(-10.00) 1D
Jun 15, 2:24:26 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003120...
Open
₩20,000
High
₩20,300
Low
₩19,820
Mkt. cap
265.47B
Avg. vol.
6.96K
Volume
4.24K
Dividend
6.01%
Quarterly dividend
₩300
Ex-dividend date
Dec 27, 2023
P/E ratio
120.59
52-wk high
₩31,450
52-wk low
₩18,100
EPS
₩166
Shares outstanding
13.30M
No. of employees
191
Open
₩20,000
High
₩20,300
Low
₩19,820
Mkt. cap
265.47B
Avg. vol.
6.96K
Volume
4.24K
Dividend
6.01%
Quarterly dividend
₩300
Ex-dividend date
Dec 27, 2023
P/E ratio
120.59
52-wk high
₩31,450
52-wk low
₩18,100
EPS
₩166
Shares outstanding
13.30M
No. of employees
191
News stories
From sources across the web
About Ilsung IS Co Ltd
CEO-
Employees191
Founded1954
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
16.26B
16.76B
14.65B
16.71B
Cost of goods sold
9.47B
9.41B
8.34B
8.88B
Cost of revenue
9.47B
9.41B
8.34B
8.88B
Research and development expenses
78.47M
254.01M
149.26M
42.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.15B
7.50B
7.19B
7.85B
Operating expense
9.07B
8.20B
8.32B
8.33B
Total operating expenses
18.54B
17.61B
16.66B
17.20B
Operating income
-2.29B
-845.36M
-2.01B
-495.46M
Other non operating income
-681.66M
-962.56M
41.50M
27.85M
EBT including unusual items
-3.68B
73.11M
4.52B
1.63B
EBT excluding unusual items
-2.32B
44.73M
10.32B
1.62B
Income tax expense
437.28M
-267.92M
1.11B
54.34M
Effective tax rate
-11.87%
-366.47%
24.55%
3.33%
Other operating expenses
431.61M
43.92M
582.89M
11.42M
Net income
-4.12B
341.03M
3.41B
1.58B
Net profit margin
-25.35%
2.03%
23.25%
9.44%
Earnings per share
-
-
-
-
Interest and investment income
1.07B
1.57B
12.09B
1.73B
Interest expense
-8.74M
-8.40M
-9.26M
-10.22M
Net interest expenses
1.06B
1.57B
12.08B
1.72B
Depreciation and amortization charges
314.98M
312.30M
311.80M
313.18M
EBITDA
-1.44B
-19.79M
-1.23B
263.08M
Gain or loss from assets sale
-
-28.33M
-
-7.27M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more